Our Technology

Enhancing the immune system to detect & attack cancer cells


Cancer Immunotherapy

"Immunotherapy is a new class of cancer treatment that works to harness the innate powers of the immune system to fight cancer. Because of the immune system's unique properties, these therapies may hold greater potential than current treatment approaches to fight cancer, to offer longer-term protection against the disease with comparatively minimum side effects."

immunotherapy image

Why Immunotherapy ?


immuno image
Powerful

Detects & Attacks cancer cells throughout the body


immuno image
Specific

Trains the immune system to detect and attack cancer cells only.

immuno image
Memory

Capacity of memory means durability of protection


immuno image
Universal

The treatment technology can be used for the treatment of other types of cancers as well

immuno image
Minimal Side-Effects

Immunotherapy is customised using the patient’s own tumour tissue & monocytes which reduces the chances of side-effects

APAC Therapeutic Platform


immuno image

The potential to harness the potency and specificity of the immune system underlies the growing interest in cancer immunotherapy. One such approach uses bone marrow–derived dendritic cells, phenotypically distinct and extremely potent antigen-presenting cells, to present tumorassociated antigens and thereby generate tumor-specific immunity.

Support for this strategy comes from animal studies that have demonstrated that dendritic cells, when loaded ex vivo with tumour antigens and administered to tumour-bearing hosts, can elicit T cell– mediated tumour destruction. These observations have led to clinical trials designed to investigate the immunologic and clinical effects of antigen-loaded dendritic cells administered as a therapeutic vaccine to patients with cancer. In the design of this personalised therapy, important considerations include antigen selection, methods for introducing the antigen into MHC class I and II processing pathways, methods for isolating and activating dendritic cells, and route of administration needs to be considered.

Promising results from clinical trials in patients with various malignancies suggest that immunotherapeutic strategies that take advantage of the antigen presenting properties of dendritic cells may ultimately prove both efficacious and widely applicable to human tumours.

©2017 - 2018 Apac Biotech Pvt Ltd. All Rights Reserved.